
EA Pharma Co., Ltd. was established from the Eisai Group’s gastrointestinal (GI) disease business. We have business mainly in Japan. In addition to GI, EA Pharma expands its therapeutic area to Psychiatry space since our sales force provides chronic constipation drug “GOOFICE®” and “MOVICOL®” to the psychiatrists. At this conference, we are seeking for in-licensing opportunities in GI diseases and phychiatric drugs.
Address
TokyoTokyo
Japan